Literature DB >> 17339256

Functional polymorphisms in the promoters of MMP-1, MMP-2, MMP-3, MMP-9, MMP-12 and MMP-13 are not associated with hepatocellular carcinoma risk.

Yun Zhai, Wei Qiu, Xiao-Jia Dong, Xiu-Mei Zhang, Wei-Min Xie, Hong-Xing Zhang, Xiao-Yan Yuan, Gang-Qiao Zhou, Fu-Chu He.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17339256      PMCID： PMC1856787          DOI： 10.1136/gut.2006.112706

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  9 in total

Review 1.  New functions for the matrix metalloproteinases in cancer progression.

Authors:  Mikala Egeblad; Zena Werb
Journal:  Nat Rev Cancer       Date:  2002-03       Impact factor: 60.716

2.  Matrix metalloproteinase (MMP) -1, -2, -3 and -9 promoter polymorphisms in colorectal cancer.

Authors:  Nils Elander; Peter Söderkvist; Karin Fransén
Journal:  Anticancer Res       Date:  2006 Jan-Feb       Impact factor: 2.480

Review 3.  Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases.

Authors:  S Ye
Journal:  Matrix Biol       Date:  2000-12       Impact factor: 11.583

4.  Polymorphisms in the promoter regions of the matrix metalloproteinases-1, -3, -7, and -9 and the risk of epithelial ovarian cancer in China.

Authors:  Yan Li; Xia Jin; Shan Kang; Ying Wang; Hui Du; Jianhui Zhang; Wei Guo; Na Wang; Shumei Fang
Journal:  Gynecol Oncol       Date:  2005-11-08       Impact factor: 5.482

5.  Estrogen receptor alpha polymorphisms associated with susceptibility to hepatocellular carcinoma in hepatitis B virus carriers.

Authors:  Yun Zhai; Gangqiao Zhou; Guohong Deng; Weimin Xie; Xiaojia Dong; Xiumei Zhang; Ling Yu; Hao Yang; Xiaoyan Yuan; Hongxin Zhang; Lianteng Zhi; Zhijian Yao; Yan Shen; Boqing Qiang; Fuchu He
Journal:  Gastroenterology       Date:  2006-03-06       Impact factor: 22.682

6.  Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation.

Authors:  S J Price; D R Greaves; H Watkins
Journal:  J Biol Chem       Date:  2000-12-12       Impact factor: 5.157

7.  Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer.

Authors:  Chunyuan Yu; Yifeng Zhou; Xiaoping Miao; Ping Xiong; Wen Tan; Dongxin Lin
Journal:  Cancer Res       Date:  2004-10-15       Impact factor: 12.701

8.  Functional polymorphisms of matrix metalloproteinase-9 are associated with risk of occurrence and metastasis of lung cancer.

Authors:  Zhibin Hu; Xiang Huo; Daru Lu; Ji Qian; Jiannong Zhou; Yijiang Chen; Lin Xu; Hongxia Ma; Jingfu Zhu; Qingyi Wei; Hongbing Shen
Journal:  Clin Cancer Res       Date:  2005-08-01       Impact factor: 12.531

9.  Polymorphisms in the promoter regions of MMP-2, MMP-3, MMP-9 and MMP-12 genes as determinants of aneurysmal coronary artery disease.

Authors:  Nicolas Lamblin; Christophe Bauters; Xavier Hermant; Jean-Marc Lablanche; Nicole Helbecque; Philippe Amouyel
Journal:  J Am Coll Cardiol       Date:  2002-07-03       Impact factor: 24.094
  9 in total
  13 in total

1.  The polymorphism MMP1 -1607 (1G>2G) is associated with a significantly increased risk of cancers from a meta-analysis.

Authors:  Lili Lu; Yujiao Sun; Yiqun Li; Ping Wan
Journal:  Tumour Biol       Date:  2014-11-13

2.  Common polymorphism in the MMP-13 gene may contribute to the risk of human cancers: a meta-analysis.

Authors:  Ping Gao; Jun-Lan Yang; Hong Zhao; Jun-Hao You; Yi Hu
Journal:  Tumour Biol       Date:  2014-07-15

3.  Single-nucleotide polymorphisms of matrix metalloproteinases and their inhibitors in gastrointestinal cancer.

Authors:  Alexandra Mj Langers; Hein W Verspaget; Daniel W Hommes; Cornelis Fm Sier
Journal:  World J Gastrointest Oncol       Date:  2011-06-15

Review 4.  Association between MMP-12-82A/G polymorphism and cancer risk: a meta-analysis.

Authors:  Luliang Liu; Jinhuan Sun; Guolin Li; Boyu Gu; Xiaolong Wang; Huirong Chi; Fulin Guo
Journal:  Int J Clin Exp Med       Date:  2015-08-15

5.  The association between MMP-12 82 A/G polymorphism and susceptibility to various malignant tumors: a meta-analysis.

Authors:  Sheng-Song Chen; Juan Song; Xiao-Yun Tu; Ji-Hua Zhao; Xiao-Qun Ye
Journal:  Int J Clin Exp Med       Date:  2015-07-15

6.  Update analysis of studies on the MMP-9 -1562 C>T polymorphism and cancer risk.

Authors:  Li-Feng Zhang; Yuan-Yuan Mi; Qiang Cao; Wei Wang; Chao Qin; Jun-Feng Wei; Yao-Jun Zhou; Yong-Fei Li; Min Tang; Wei-Min Liu; Wei Zhang; Jian-Gang Zou
Journal:  Mol Biol Rep       Date:  2011-06-30       Impact factor: 2.316

7.  The Contribution of Matrix Metalloproteinase-1 Genotypes to Hepatocellular Carcinoma Susceptibility in Taiwan.

Authors:  Yi-Liang Lai; Chi-Li Gong; Chun-Kai Fu; Te-Cheng Yueh; Chia-Wen Tsai; Wen-Shin Chang; Chieh-Lun Hsiao; Shiou-Ting Yen; Hsin-Ting Li; Long-Bin Jeng; Shou-Cheng Wang; DA-Tian Bau
Journal:  Cancer Genomics Proteomics       Date:  2017 Mar-Apr       Impact factor: 4.069

Review 8.  Meta-analysis of association of the matrix metalloproteinase 2 (-735 C/T) polymorphism with cancer risk.

Authors:  Su Kang Kim; Sang Wook Kang; Hae Jeong Park; Ju Yeon Ban; Chung-Hun Oh; Joo-Ho Chung; In-Hwan Oh; Kyu Bong Cho; Min-Su Park
Journal:  Int J Clin Exp Med       Date:  2015-10-15

9.  Optimizing the Diagnostic Role of Alpha-Fetoprotein and Abdominal Ultrasound by Adding Overexpressed Blood mRNA Matrix Metalloproteinase-12 for Diagnosis of HCV-Related Hepatocellular Carcinoma.

Authors:  Esam Elshimi; Mostafa Abdel-Samed Mostafa Sakr; Wesam Saber Morad; Lobna Mohammad
Journal:  Gastrointest Tumors       Date:  2019-01-09

10.  Association of matrix metalloproteinase-3 -1171(5A>6A) polymorphism with cancer risk: a meta-analysis of 41 studies.

Authors:  Xin Yang; Jing-Wen Hu; Man-Tang Qiu; Ming Li; Rong Yin; Jie Wang; Lin Xu; Qin Zhang
Journal:  PLoS One       Date:  2014-01-29       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.